DTU Logo
About the DTU | News | Staff | Alumni | Contact/Find us

Professor Rury Holman



Publications (17 of 319)


Search Publications :

2006

Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
Kahn SE, Haffner SM, Heise MA, Herman WH, Holman RR, Jones NP, Kravitz BG, Lachin JM, O'Neill MC, Zinman B, Viberti G for the ADOPT Study Group
N Eng J Med 2006;355:2427-43. Published:07-Dec-2006. Epub:04-Dec-2006. PMID:17145742. doi:10.1056/NEJMoa066224
[Abstract] [Slides]
Erratum in :
N Eng J Med 2007;356:1387-8, Print:29-Mar-2007, doi:10.1056/NEJMx070014

A Diabetes Outcome Progression Trial (ADOPT): baseline characteristics of Type 2 diabetic patients in North America and Europe
Viberti G, Lachin J, Holman R, Zinman B, Haffner S, Kravitz B, Heise MA, Jones NP, O'Neill MC, Freed MI, Kahn SE, Herman WH for the ADOPT Study Group
Diabetic Medicine 2006;23:1289-1294. Published:Dec-2006. Epub:17-Nov-2006. PMID:17116177. doi:10.1111/j.1464-5491.2006.02022.x
[Abstract]

Paraoxonase2 (PON2) Polymorphisms and Development of Renal Dysfunction in Type 2 Diabetes: UKPDS 76
Calle R, McCarthy MI, Banerjee P, Zeggini E, Cull CA, Thorne KI, Wiltshire S, Terra S, Meyer D, Richmond J, Mancuso J, Milos P, Fryburg D, Holman RR
Diabetologia 2006;49:2892-2899. Published:Dec-2006. Epub:03-Oct-2006. PMID:17096118. doi:10.1007/s00125-006-0436-8
[Abstract]

Hypoglycemia in Type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS73
Wright AD, Cull CA, Macleod KM, Holman RR for the UKPDS Group
J Diabetes Complications 2006;20:402-408. Published:Nov-2006. Epub:25-Oct-2006. PMID:17070446. doi:10.1016/j.jdiacomp.2005.08.010
[Abstract]

A Clinical Screening Tool Identifies Autoimmune Diabetes in Adults: Response to Fourlanos et al.
Timothy M.E. Davis, Carole A. Cull and Rury R. Holman
Diabetes Care 2006;29:2560. Published:Nov-2006. PMID:17065707. doi:10.2337/dc06-1321

Effect of Ramipril on the Incidence of diabetes
Bosch J, Yusuf S, Gerstein HC, Pogue J, Sheridan P, Dagenais G, Diaz R, Avezum A, Lanas F, Probstfield J, Fodor G, Holman RR for the DREAM Trial Investigators
N Eng J Med 2006;355:1551-62. Published:12-Oct-2006. Epub:15-Sep-2006. PMID:16980380. doi:10.1056/NEJMoa065061

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial
Gerstein HC, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, Hanefeld M, Hoogwerf B, Laakso M, Mohan V, Shaw J, Zinman B, Holman RR on behalf of the DREAM trial investigators
Lancet 2006;368:1096-105. Published:15-Sep-2006. Epub:20-Sep-2006. PMID:16997664. doi:10.1016/S0140-6736(06)69420-8
Erratum in :
Lancet 2006;368:1770

Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B
Diabetes Care 2006;29:1963-1972. Published:Aug-2006. Epub:27-Jun-2006. PMID:16873813. doi:10.2337/dc06-9912
Erratum in :
Diabetes Care 2006;49:2816-8, Print:Nov-2006

Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B
Diabetologia 2006;49:1711-1721. Published:Aug-2006. Epub:27-Jun-2006. PMID:16802130. doi:10.1007/s00125-006-0316-2
Erratum in :
Diabetologia 2006;49:2816-2818, Print:Nov-2006, Epub:13-Sep-2006, doi:10.1007/s00125-006-0415-0

Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75)
Stratton IM, Cull CA, Adler AI, Matthews DR, Neil HA, Holman RR
Diabetologia 2006;49:1761-1769. Published:Aug-2006. Epub:31-May-2006. PMID:16736131. doi:10.1007/s00125-006-0297-1
[Abstract]

Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes
Kahn SE, Zinman B, Haffner SM, O'Neill MC, Kravitz BG, Yu D, Freed MI, Herman WH, Holman RR, Jones NP, Lachin JM, Viberti GC and the ADOPT Study Group
Diabetes 2006;55:2357-2364. Published:Aug-2006. PMID:16873701. doi:10.2337/db06-0116
[Abstract]

Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials
Stettler C, Allemann S, Jüni P, Cull CA, Holman RR, Egger M, Krähenbühl S, Diem P
American Heart Journal 2006;152:27-38. Published:Jul-2006. Epub:13-Jul-2006. PMID:16824829. doi:10.1016/j.ahj.2005.09.015
[Abstract]

Assessing the Impact of Visual Acuity on Quality of Life in Individuals With Type 2 Diabetes Using the Short Form-36
Clarke PM, Simon J, Cull CA, Holman RR
Diabetes Care 2006;29:1506-1511. Published:Jul-2006. PMID:16801570. doi:10.2337/dc05-2150
[Abstract]

Risk Factors for Renal Dysfunction in Type 2 Diabetes
Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR for the UKPDS study group
Diabetes 2006;55:1832-1839. Published:Jun-2006. PMID:16731850. doi:10.2337/db05-1620
[Abstract]

The Variable Number of Tandem Repeats Upstream of the Insulin Gene Is a Susceptibility Locus for Latent Autoimmune Diabetes in Adults
Desai M, Zeggini E, Horton VA, Owen KR, Hattersley AT, Levy JC, Hitman GA, Walker M, Holman RR, McCarthy MI, Clark A
Diabetes 2006;55:1890-1894. Published:Jun-2006. PMID:16731859. doi:10.2337/db06-0089
[Abstract]

Long-term efficacy of sulfonylureas: a United Kingdom Prospective Diabetes Study perspective
Holman RR
Metabolism Clinical and Experimental 2006;55 (Suppl 1):S2-S5. Published:May-2006. PMID:16631806. doi:10.1016/j.metabol.2006.02.006
[Abstract]

PROactive Study
Holman RR, Retnakaran R, Farmer A, Stevens RJ
Lancet 2006;367:25-26. Published:07-Jan-2006. Epub:05-Jan-2006. PMID:16399144. doi:10.1016/S0140-6736(06)67914-2